AIMs of the call

EuroNanoMed aims (i) to support translational research projects that combine innovative approaches in the field of nanomedicine and; (ii) to encourage and enable transnational collaboration between public and private research groups from academia, clinical/public health research or research teams from industrial enterprises (all size). The participation of Medical Doctors and SMEs will be strongly encouraged.

TOPICS of the call

Project proposals will address multidisciplinary and translational research. Project proposals will need to cover at least one of the following areas that are equal in relevance for this call:

Regenerative medicine

Diagnostics

Targeted delivery syste ms

The projects should fall within Technology Readiness Levels (TRL)[1] 3-6, although for being realistic and coherent with the characteristics of the call, projects should propose advancements for a maximum of two TRL levels during their lifetime.

General conditions for application

A consortium applying to this call will be required to include research group(s) from at least 2 of the 3 following categories, if eligible according to relevant national/regional funding organisations’ regulations for research funding^[1]:

1. Academia (research teams working in universities, other higher education institutions or research institutes);

2. Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations). Participation of Medical Doctors is encouraged;

3. Enterprise (all sizes of private companies). Participation of small and medium-size enterprises (SMEs) will be encouraged.

Please note! Whilst applications will be submitted jointly by groups from several countries, individual groups will be funded by the individual EuroNanoMed III funding organisation respective of the country/region from which applicants have applied. The applications are therefore subjected to eligibility criteria of individual funding organisations. Applicants are strongly advised to contact their national representatives as soon as possible in order to confirm with their eligibility.

Only transnational projects will be funded. Each consortium submitting a proposal will need to involve a minimum of 3 eligible and a maximum of 5 eligible partners from at least 3 different countries participating to the call (see list below) though no more than 2 eligible partners from the same country participating in the call will be accepted in one consortium.

Research groups not eligible to be funded (e.g. from non-funding countries or not fundable according to national/regional regulations of the participating funding countries) may participate in transnational projects if they are able to secure their own funding. However, no more than one research group with own funding can be included in a consortium and the coordinator must be eligible to be funded by EuroNanoMed III participating countries/regions.

The maximum number of partners will possibly be increased from 5 to 7 (including eligible for funding and non-eligible for funding research groups) if partners from these participating countries, which are either new in the EuroNanoMed consortium or their community has been under-represented in past EuroNanoMed calls: Belgium, Estonia, Ireland, Latvia, Lithuania, Romania, Slovakia, Taiwan, and Turkey

Deadlines

• Opening of the submission web tool: 28^th November 2016
• Submission deadline for pre-proposals: 16^th January 2017
• Submission deadline of full proposals: 9^th June 2017